These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 18004153)

  • 1. Sibutramine and psychosis.
    Litvan L; Alcoverro-Fortuny O
    J Clin Psychopharmacol; 2007 Dec; 27(6):726-7. PubMed ID: 18004153
    [No Abstract]   [Full Text] [Related]  

  • 2. Psychosis with sibutramine.
    Rosenbohm A; Bux CJ; Connemann BJ
    J Clin Psychopharmacol; 2007 Jun; 27(3):315-7. PubMed ID: 17502790
    [No Abstract]   [Full Text] [Related]  

  • 3. Catatonia and psychosis associated with sibutramine: a case report and pathophysiologic correlation.
    Lee J; Teoh T; Lee TS
    J Psychosom Res; 2008 Jan; 64(1):107-9. PubMed ID: 18158006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case of psychosis associated with Pai You Guo slimming capsules containing sibutramine.
    Shah KA; Abraham MA; Espinosa JB
    J Clin Psychiatry; 2015 Jul; 76(7):e893-4. PubMed ID: 26231019
    [No Abstract]   [Full Text] [Related]  

  • 5. Tolerability of sibutramine during a 6-week treatment period in high-risk patients with cardiovascular disease and/or diabetes: a preliminary analysis of the Sibutramine Cardiovascular Outcomes (SCOUT) Trial.
    Maggioni AP; Caterson I; Coutinho W; Finer N; Gaal LV; Sharma AM; Torp-Pedersen C; Bacher P; Shepherd G; Sun R; James P;
    J Cardiovasc Pharmacol; 2008 Nov; 52(5):393-402. PubMed ID: 19033818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controversy about the cardiovascular safety of sibutramine.
    Scheen AJ
    Drug Saf; 2010 Jul; 33(7):615-8. PubMed ID: 20553062
    [No Abstract]   [Full Text] [Related]  

  • 7. Misuse of sibutramine and bulimia nervosa: a dangerous combination.
    Ferreira GM; Nazar BP; da Silva MR; Carriello MA; Freitas S; Appolinario JC
    Braz J Psychiatry; 2018; 40(3):343. PubMed ID: 30043896
    [No Abstract]   [Full Text] [Related]  

  • 8. [Adverse drug reactions of a slimming product contaminated with sibutramine].
    van Hunsel F; van Grootheest K
    Ned Tijdschr Geneeskd; 2011; 155(42):A3695. PubMed ID: 22027464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sibutramine-associated psychosis (case report).
    Gazdag G; Szabó Z
    Neuropsychopharmacol Hung; 2008 May; 10(2):107-10. PubMed ID: 18959143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The anti-obesity drug sibutramine for overweight diabetic patients. "Blood pressure is not elevated")].
    Matiba B
    MMW Fortschr Med; 2002 Jul; 144(27-28):16; author reply 17. PubMed ID: 12198873
    [No Abstract]   [Full Text] [Related]  

  • 11. Sibutramine-associated psychotic symptoms and zolpidem-induced complex behaviours: implications for patient safety.
    Wiglusz MS; Cubała WJ; Nowak P; Jakuszkowiak-Wojten K; Landowski J; Krysta K
    Psychiatr Danub; 2013 Sep; 25 Suppl 2():S143-5. PubMed ID: 23995163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe symptomatic hyponatremia during sibutramine therapy: a case report.
    Esposito P; Rampino T; Gregorini M; Soccio G; Piotti G; Bedino G; Balenzano CT; Roscini E; Cosmai L; Portalupi V; Libetta C; Dal Canton A
    Am J Kidney Dis; 2008 Jul; 52(1):137-9. PubMed ID: 18487000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sibutramine for obesity.
    Med Lett Drugs Ther; 1998 Mar; 40(1022):32. PubMed ID: 9529518
    [No Abstract]   [Full Text] [Related]  

  • 14. [Questions surrounding sibutramine for obesity].
    Nau JY
    Rev Med Suisse; 2010 Jan; 6(231):76. PubMed ID: 20196440
    [No Abstract]   [Full Text] [Related]  

  • 15. Sibutramine-associated psychotic episode.
    Taflinski T; Chojnacka J
    Am J Psychiatry; 2000 Dec; 157(12):2057-8. PubMed ID: 11097984
    [No Abstract]   [Full Text] [Related]  

  • 16. Diet pill psychosis.
    Hoffman BF
    Can Med Assoc J; 1977 Feb; 116(4):351-5. PubMed ID: 844014
    [No Abstract]   [Full Text] [Related]  

  • 17. Sibutramine: an Australian analysis of reported adverse effects.
    Prescrire Int; 2007 Jun; 16(89):114. PubMed ID: 17590911
    [No Abstract]   [Full Text] [Related]  

  • 18. European Medicines Agency withdrawal for sibutramine.
    Galhardo J; Davis N; Matthai S; Shield JP
    Arch Dis Child; 2010 Oct; 95(10):856. PubMed ID: 20573736
    [No Abstract]   [Full Text] [Related]  

  • 19. [Abuse potential of sibutramine].
    Saiz Ruiz J; Saiz González D; Antón Fructuoso P
    Med Clin (Barc); 2003 May; 120(16):639. PubMed ID: 12732133
    [No Abstract]   [Full Text] [Related]  

  • 20. Bruising associated with sibutramine: results from postmarketing surveillance in New Zealand.
    Harrison-Woolrych M; Hill GR; Clark DW
    Int J Obes (Lond); 2006 Aug; 30(8):1315-7. PubMed ID: 16491106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.